For both viral infections (HIV, HBV), we observed the highest improvements in antiviral activity when all four IFNAR1 binding sites (positions 82, 86, 89, and 120), which differ between IFNα2 and IFNα14, were mutated. This evidence concerns the gene IFNA14 and viral infectious disease.